Insulin intensification targets postprandial hyperglycemia and can be accomplished either by adding one (basal-plus) or more (basal-bolus) prandial insulin injections, or by adding a GLP-1 receptor agonist (GLP-1 RA) if the patient is not already under such therapy. Here, GLP1R is linked to Hyperglycemia.